Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes

SGLT-2i do not prevent C-AKI in patients with diabetes. Further research is required to explore alternative nephroprotective strategies.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-10-28
DOI
https://doi.org/10.21873/anticanres.17858
Primary Topic
Chemotherapy-induced organ toxicity mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes

Masaya Takahashi, Hitomi Nakatsukasa, Yasutaka Nakamura, Yusuke Ishigami et al.
Anticancer Research
Chemotherapy-induced organ toxicity mitigation
article

Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes

Masaya Takahashi, Hitomi Nakatsukasa, Yasutaka Nakamura, Yusuke Ishigami, Yuya Kohara, Hironobu Nishiura
article en

Abstract

SGLT-2i do not prevent C-AKI in patients with diabetes. Further research is required to explore alternative nephroprotective strategies.

Anticancer ResearchVol. 45(11)
Osaka University Hospital (JP), Osaka City University Hospital (JP), Osaka Metropolitan University (JP)
Openalex Percentile: Top 56%
Chemotherapy-induced organ toxicity mitigation
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.